Press Release Archive

Information on this page is updated via a feed from the London Stock Exchange's Regulatory News Service. To retrieve the full story please click on the headline. Stories will open in a new window.

Search Options






    
 
View Previous Stories.Previous Stories


Search Results
DateTimeHeadline
31/08/201010:33Ark Therapeutics Group PLC - Total Voting Rights
27/08/201010:08Piper Jaffray Ltd - Form 8.5 (EPT/NON-RI)
25/08/201007:00Ark Therapeutics Group PLC - Half Yearly Report
20/08/201014:27Gartmore Investment Management Ltd Form 8.3 - Ark Therapeutics Group Plc
19/08/201011:35Piper Jaffray Ltd - Form 8.5 (EPT/NON-RI)
16/08/201012:29Smith & Williamson Investment Mngmt - Form 8.3 - Ark Therapeutics Group plc
16/08/201007:00D & K Phillips - Form 8.3 - Ark Therapeutics PLC (Amendment)
13/08/201016:24Ark Therapeutics Group PLC - Re EGM
13/08/201011:34Piper Jaffray Ltd - Form 8.5 (EPT/NON-RI)
13/08/201011:22Credit Suisse Securities (Eur) Ltd - Form 8.5 (EPT/RI)
13/08/201010:30D & K Phillips - Form 8.3 - Ark Therapeutics PLC
11/08/201011:35GAM (UK) Ltd - Form 8.3 - [Ark Therapeutics Plc]
05/08/201012:31GAM (UK) Ltd - Form 8.3 - Ark Therapeutics Group PLC
04/08/201016:41Ark Therapeutics Group PLC - Second Price Monitoring Extn
04/08/201016:35Ark Therapeutics Group PLC - Price Monitoring Extension
04/08/201010:00Smith & Williamson Investment Mngmt - Form 8.3 - Ark Therapeutics Group
03/08/201010:47Smith & Williamson Investment Mngmt - Form 8.3 - Ark Therapeutics
30/07/201011:22GAM International Management Ltd - Form 8.3 - Ark Therapeutics Plc
29/07/201010:34Piper Jaffray Ltd - Form 8.5 (EPT/NON-RI)
28/07/201011:03Piper Jaffray Ltd - Form 8.5 (EPT/NON-RI)
28/07/201010:36Ark Therapeutics Group PLC - Holding(s) in Company
28/07/201010:30D & K Phillips - Form 8.3 - Ark Therapeutics
28/07/201010:01Ark Therapeutics Group PLC - Holding(s) in Company
26/07/201014:57Smith & Williamson Investment Mngmt - Form 8.3 - [Ark Therapeutics]
26/07/201014:41Gartmore Investment Management Ltd Form 8.3 - ARK THERAPEUTICS
26/07/201011:37Piper Jaffray Ltd - Form 8.5 (EPT/NON-RI)
23/07/201011:57Piper Jaffray Ltd - Form 8.5 (EPT/NON-RI)
23/07/201011:15Smith & Williamson Investment Mngmt - Form 8.3 - Ark Therapeutics Group plc
22/07/201014:35Gartmore Investment Management Ltd Form 8.3 - Ark Theraputics Plc
22/07/201012:54Smith & Williamson Investment Mngmt - Form 8.3 - Ark Therapeutics Group plc
22/07/201011:19Piper Jaffray Ltd - Form 8.5 (EPT/NON-RI)
22/07/201010:55Legal & General Investment Mgmnt Ld - Form 8.3 - Ark Therapeutics Group Plc
21/07/201014:41Legal & General Investment Mgmnt Ld - Form 8.3 - Ark Therapeutics Plc
21/07/201010:54Piper Jaffray Ltd - Form 8.5 (EPT/NON-RI)
20/07/201011:35Piper Jaffray Ltd - Form 8.5 (EPT/NON-RI)
20/07/201011:00Credit Suisse Securities (Eur) Ltd - Form 8.5 (EPT/RI)
20/07/201010:46Smith & Williamson Investment Mngmt - Form 8.3 - [Ark Therapeutics]
19/07/201011:39Credit Suisse Securities (Eur) Ltd - Form 8.5 (EPT/RI)
19/07/201011:33Credit Suisse Securities (Eur) Ltd - Form 8.5 (EPT/RI)- Amendment 15/07
19/07/201011:26Smith & Williamson Investment Mngmt - Form 8.3 - Ark Therapeutics
16/07/201012:07Credit Suisse Securities (Eur) Ltd - Form 8.5 (EPT/RI)
15/07/201013:06GAM International Management Ltd - Form 8.3 - Ark Therapeutics Group PLC
13/07/201007:00Ark Therapeutics Group PLC - ARK UPDATE AND BOARD CHANGES
09/07/201010:16D & K Phillips - Form 8.3 - Ark Therapeutics Group PLC - Amendment
08/07/201010:27D & K Phillips - Form 8.3 - Ark Therapeutics Group PLC
07/07/201013:55Gartmore Investment Management Ltd Form 8.3 - Ark Therapeutic Group Plc
07/07/201011:50Piper Jaffray Ltd - Form 8.5 (EPT/NON-RI)
06/07/201014:49Gartmore Investment Management Ltd Form 8.3 - Ark Therapeutics Groups Plc
06/07/201011:36Piper Jaffray Ltd - Form 8.5 (EPT/NON-RI)
02/07/201014:15Gartmore Investment Management Ltd Form 8.3 - Ark Therapeutic Group Plc
View Previous Stories.Previous Stories



Data provided by Hemscott Group Limited.
Share Price
4.65p

Change: 0.25p

At: 07/09/2010 8:20:12

Annual Reports Keep up to date
Keep up-to-date with product developments, investor relations information and news with our email updates. Register here to receive our email alerts.